Life sciences company Labcorp chooses Nasdaq for unit's listing
June 9 (Reuters) - Life sciences company Labcorp LH.N said on Friday its clinical development unit, Fortrea, will be listed on Nasdaq. (Reporting by Niket Nishant in Bengaluru; Editing by Krishna Chandra Eluri) ((Niket.Nishant@thomsonreuters.com;))
Recent news on Laboratory of America Holdings
See all newsBrief: Labcorp To Announce Second Quarter 2026 Financial Results On July 30, 2026
Brief: Labcorp And Epic Expand Collaboration To Advance Diagnostic Integration Across Hospitals And Health Systems
U.S. STOCKS ON THE MOVE-Quanta, O'Reilly Automotive, Avis
Labcorp lifts full‑year forecast as diagnostics business stays resilient (updated)
U.S. STOCKS ON THE MOVE-Qualcomm, Meta, Cardinal Health